Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model

L. Fracaro, F. C V Frez, B. C. Silva, G. E. Vicentini, S. R G de Souza, H. A. Martins, David R Linden, F. A. Guarnier, J. N. Zanoni

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Cachexia is a significant problem in patients with cancer. The effect of cancer on interstitial cells of Cajal (ICC) and neurons of the gastrointestinal tract have not been studied previously. Although supplementation with L-glutamine 2% may have beneficial effects in cancer-related cachexia, and be protective of ICC in models of oxidative stress such as diabetes, its effects on ICC in cancer have also not been studied. Methods: Twenty-eight male Wistar rats were divided into four groups: control (C), control supplemented with L-glutamine (CG), Walker 256 tumor (WT), and Walker 256 tumor supplemented with L-glutamine (WTG). Rats were implanted with tumor cells or injected with saline in the right flank. After 14 days, the jejunal tissues were collected and processed for immunohistochemical techniques including whole mounts and cryosections and Western blot analysis. Key Results: Tumor-bearing rats demonstrate reduced numbers of Myenteric ICC and deep muscular plexus ICC and yet increased Ano1 protein expression and enhanced ICC networks. In addition, there is more nNOS protein expressed in tumor-bearing rats compared to controls. L-glutamine treatment had a variety of effects on ICC that may be related to the disease state and the interaction of ICC and nNOS neurons. Regardless, L-glutamine reduced the size of tumors and also tumor-induced cachexia that was not due to altered food intake. Conclusions & Inferences: There are significant effects on ICC in the Walker 256 tumor model. Although supplementation with L-glutamine has differential and complex effects of ICC, it reduces tumor size and tumor-associated cachexia, which supports its beneficial therapeutic role in cancer.

Original languageEnglish (US)
Pages (from-to)101-115
Number of pages15
JournalNeurogastroenterology and Motility
Volume28
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Interstitial Cells of Cajal
Neoplasms
Glutamine
Cachexia
Neurons

Keywords

  • Antioxidants
  • Cancer
  • Enteric nervous system
  • Immunohistochemistry
  • Intestinal motility

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Gastroenterology
  • Physiology

Cite this

Fracaro, L., Frez, F. C. V., Silva, B. C., Vicentini, G. E., de Souza, S. R. G., Martins, H. A., ... Zanoni, J. N. (2016). Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model. Neurogastroenterology and Motility, 28(1), 101-115. https://doi.org/10.1111/nmo.12702

Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model. / Fracaro, L.; Frez, F. C V; Silva, B. C.; Vicentini, G. E.; de Souza, S. R G; Martins, H. A.; Linden, David R; Guarnier, F. A.; Zanoni, J. N.

In: Neurogastroenterology and Motility, Vol. 28, No. 1, 01.01.2016, p. 101-115.

Research output: Contribution to journalArticle

Fracaro, L, Frez, FCV, Silva, BC, Vicentini, GE, de Souza, SRG, Martins, HA, Linden, DR, Guarnier, FA & Zanoni, JN 2016, 'Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model', Neurogastroenterology and Motility, vol. 28, no. 1, pp. 101-115. https://doi.org/10.1111/nmo.12702
Fracaro, L. ; Frez, F. C V ; Silva, B. C. ; Vicentini, G. E. ; de Souza, S. R G ; Martins, H. A. ; Linden, David R ; Guarnier, F. A. ; Zanoni, J. N. / Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model. In: Neurogastroenterology and Motility. 2016 ; Vol. 28, No. 1. pp. 101-115.
@article{268447fa4a694264a253195560a87e60,
title = "Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model",
abstract = "Background: Cachexia is a significant problem in patients with cancer. The effect of cancer on interstitial cells of Cajal (ICC) and neurons of the gastrointestinal tract have not been studied previously. Although supplementation with L-glutamine 2{\%} may have beneficial effects in cancer-related cachexia, and be protective of ICC in models of oxidative stress such as diabetes, its effects on ICC in cancer have also not been studied. Methods: Twenty-eight male Wistar rats were divided into four groups: control (C), control supplemented with L-glutamine (CG), Walker 256 tumor (WT), and Walker 256 tumor supplemented with L-glutamine (WTG). Rats were implanted with tumor cells or injected with saline in the right flank. After 14 days, the jejunal tissues were collected and processed for immunohistochemical techniques including whole mounts and cryosections and Western blot analysis. Key Results: Tumor-bearing rats demonstrate reduced numbers of Myenteric ICC and deep muscular plexus ICC and yet increased Ano1 protein expression and enhanced ICC networks. In addition, there is more nNOS protein expressed in tumor-bearing rats compared to controls. L-glutamine treatment had a variety of effects on ICC that may be related to the disease state and the interaction of ICC and nNOS neurons. Regardless, L-glutamine reduced the size of tumors and also tumor-induced cachexia that was not due to altered food intake. Conclusions & Inferences: There are significant effects on ICC in the Walker 256 tumor model. Although supplementation with L-glutamine has differential and complex effects of ICC, it reduces tumor size and tumor-associated cachexia, which supports its beneficial therapeutic role in cancer.",
keywords = "Antioxidants, Cancer, Enteric nervous system, Immunohistochemistry, Intestinal motility",
author = "L. Fracaro and Frez, {F. C V} and Silva, {B. C.} and Vicentini, {G. E.} and {de Souza}, {S. R G} and Martins, {H. A.} and Linden, {David R} and Guarnier, {F. A.} and Zanoni, {J. N.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1111/nmo.12702",
language = "English (US)",
volume = "28",
pages = "101--115",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model

AU - Fracaro, L.

AU - Frez, F. C V

AU - Silva, B. C.

AU - Vicentini, G. E.

AU - de Souza, S. R G

AU - Martins, H. A.

AU - Linden, David R

AU - Guarnier, F. A.

AU - Zanoni, J. N.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Cachexia is a significant problem in patients with cancer. The effect of cancer on interstitial cells of Cajal (ICC) and neurons of the gastrointestinal tract have not been studied previously. Although supplementation with L-glutamine 2% may have beneficial effects in cancer-related cachexia, and be protective of ICC in models of oxidative stress such as diabetes, its effects on ICC in cancer have also not been studied. Methods: Twenty-eight male Wistar rats were divided into four groups: control (C), control supplemented with L-glutamine (CG), Walker 256 tumor (WT), and Walker 256 tumor supplemented with L-glutamine (WTG). Rats were implanted with tumor cells or injected with saline in the right flank. After 14 days, the jejunal tissues were collected and processed for immunohistochemical techniques including whole mounts and cryosections and Western blot analysis. Key Results: Tumor-bearing rats demonstrate reduced numbers of Myenteric ICC and deep muscular plexus ICC and yet increased Ano1 protein expression and enhanced ICC networks. In addition, there is more nNOS protein expressed in tumor-bearing rats compared to controls. L-glutamine treatment had a variety of effects on ICC that may be related to the disease state and the interaction of ICC and nNOS neurons. Regardless, L-glutamine reduced the size of tumors and also tumor-induced cachexia that was not due to altered food intake. Conclusions & Inferences: There are significant effects on ICC in the Walker 256 tumor model. Although supplementation with L-glutamine has differential and complex effects of ICC, it reduces tumor size and tumor-associated cachexia, which supports its beneficial therapeutic role in cancer.

AB - Background: Cachexia is a significant problem in patients with cancer. The effect of cancer on interstitial cells of Cajal (ICC) and neurons of the gastrointestinal tract have not been studied previously. Although supplementation with L-glutamine 2% may have beneficial effects in cancer-related cachexia, and be protective of ICC in models of oxidative stress such as diabetes, its effects on ICC in cancer have also not been studied. Methods: Twenty-eight male Wistar rats were divided into four groups: control (C), control supplemented with L-glutamine (CG), Walker 256 tumor (WT), and Walker 256 tumor supplemented with L-glutamine (WTG). Rats were implanted with tumor cells or injected with saline in the right flank. After 14 days, the jejunal tissues were collected and processed for immunohistochemical techniques including whole mounts and cryosections and Western blot analysis. Key Results: Tumor-bearing rats demonstrate reduced numbers of Myenteric ICC and deep muscular plexus ICC and yet increased Ano1 protein expression and enhanced ICC networks. In addition, there is more nNOS protein expressed in tumor-bearing rats compared to controls. L-glutamine treatment had a variety of effects on ICC that may be related to the disease state and the interaction of ICC and nNOS neurons. Regardless, L-glutamine reduced the size of tumors and also tumor-induced cachexia that was not due to altered food intake. Conclusions & Inferences: There are significant effects on ICC in the Walker 256 tumor model. Although supplementation with L-glutamine has differential and complex effects of ICC, it reduces tumor size and tumor-associated cachexia, which supports its beneficial therapeutic role in cancer.

KW - Antioxidants

KW - Cancer

KW - Enteric nervous system

KW - Immunohistochemistry

KW - Intestinal motility

UR - http://www.scopus.com/inward/record.url?scp=84951831878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951831878&partnerID=8YFLogxK

U2 - 10.1111/nmo.12702

DO - 10.1111/nmo.12702

M3 - Article

VL - 28

SP - 101

EP - 115

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 1

ER -